Abbott Laboratories
-
Health News
We’re buying more of this health-care company amid an overdone sell-off
[ad_1] Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the…
Read More » -
Health News
Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in…
Read More » -
Health News
Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in…
Read More » -
Health News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.…
Read More » -
Health News
‘A trove of rebound opportunities’: Strategists turn bullish on biotech and more, picking top stocks
[ad_1] 2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this…
Read More » -
Health News
AI, wearables and more — these markets are booming as the world ages. The pros share 4 stock picks
[ad_1] The world is aging rapidly, and there are more and more ways to invest in this theme. Shams Afzal,…
Read More » -
Business
Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined…
Read More » -
Health News
Can you hack your brain? These companies are driving innovation in the field of brain stimulation
[ad_1] Deep brain stimulation therapies have been around for decades, but a wave of at-home wearable devices has emerged, forging…
Read More » -
Health News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
[ad_1] Weight loss has always been big business, but it’s exploded of late due to surging demand for Ozempic, Wegovy…
Read More » -
Health News
As Covid-testing business drops, Abbott searches for new line of business with consumer wearables
[ad_1] CEO Robert Ford speaking on stage at the HLTH conference in Las Vegas. Source: Abbott Abbott Laboratories CEO Robert…
Read More »